↓ Skip to main content

A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.

Overview of attention for article published in JCEM, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs
1 blog
twitter
2 X users
f1000
1 research highlight platform

Citations

dimensions_citation
146 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.
Published in
JCEM, July 2012
DOI 10.1210/jc.2012-1520
Pubmed ID
Authors

Keith C. Bible, Vera J. Suman, Michael E. Menefee, Robert C. Smallridge, Julian R. Molina, William J. Maples, Nina J. Karlin, Anne M. Traynor, Priya Kumar, Boon Cher Goh, Wan-Teck Lim, Ayoko R. Bossou, Crescent R. Isham, Kevin P. Webster, Andrea K. Kukla, Carolyn Bieber, Jill K. Burton, Pamela Harris, Charles Erlichman

Abstract

Pazopanib, an inhibitor of kinases including vascular endothelial growth factor receptor, demonstrated impressive activity in progressive metastatic differentiated thyroid cancer, prompting its evaluation in anaplastic thyroid cancer (ATC).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
France 1 1%
Unknown 76 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 15%
Student > Ph. D. Student 11 14%
Student > Master 10 13%
Student > Bachelor 8 10%
Student > Doctoral Student 7 9%
Other 16 21%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 38 49%
Agricultural and Biological Sciences 8 10%
Biochemistry, Genetics and Molecular Biology 4 5%
Nursing and Health Professions 3 4%
Psychology 3 4%
Other 5 6%
Unknown 17 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2017.
All research outputs
#3,389,044
of 25,377,790 outputs
Outputs from JCEM
#2,665
of 15,434 outputs
Outputs of similar age
#21,690
of 177,698 outputs
Outputs of similar age from JCEM
#30
of 158 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 15,434 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,698 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.